daniel culver - Cleveland Clinic

October 28, 2022/Pulmonary/Interstitial Lung Disease

Advancements in Interstitial Lung Disease (Podcast)

Emerging trends are transforming the classification, diagnosis, therapies and management of ILD

650×450-Interstitial-Lung-Disease-Outcomes

November 19, 2020/Pulmonary/Interstitial Lung Disease

Does Accurate Diagnosis Still Matter for Interstitial Lung Disease?

Multidisciplinary approach can uncover unsuspected diagnoses

February 4, 2019/Pulmonary/Interstitial Lung Disease

The Interstitial Lung Disease Clinic’s Patient-Focused Approach

An interview with Daniel Culver, DO

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

October 25, 2018/Pulmonary/Research

Unanswered Questions in Treatment-Resistant Pulmonary Sarcoidosis

Research needed to fill critical knowledge gaps

18-PUL-4645-Tolle-Hero-Image-650x450pxl[5]

September 26, 2018/Pulmonary/Interstitial Lung Disease

How to Treat Idiopathic Pulmonary Fibrosis

An overview of available treatment modalities

July 2, 2018/Pulmonary/Interstitial Lung Disease

Pulmonary Alveolar Proteinosis: A Rare Lung Disease

An overview of PAP and our treatment approach

18-PUL-4540-Culver-Hero-Image-650x450pxl

May 21, 2018/Pulmonary/Interstitial Lung Disease

Cleveland Clinic Joins Pulmonary Fibrosis Foundation’s Care Center Network

In recognition of Respiratory Institute’s national expertise

18-RHE-1022-Hajj-Ali-Hero-Image-650x450pxl

January 16, 2018/Pulmonary

CNS Granulomata in Common Variable Immunodeficiency

A better understanding and a hope for better outcomes

Tag: daniel culver

New Study Explores Efzofitimod as a Promising Alternative for Sarcoidosis Treatment